Gene hunt aims to predict deadly diabetes drug complication
NCT ID NCT05402579
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a person's genes can help predict their risk of diabetic ketoacidosis (DKA) when taking SGLT2 inhibitors, a common class of diabetes drugs. Researchers collected DNA from 63 adults with type 2 diabetes who were either hospitalized with DKA while on the drug or were taking it without DKA. The goal was to find genetic variants that might explain why some people develop this life-threatening side effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
genomic analysis
What this could lead to
If successful, this could help doctors identify who is at higher risk of diabetic ketoacidosis when taking SGLT2 inhibitors, making the drugs safer to use.
What could go wrong
This was a small, completed study with only 63 participants. The findings are exploratory and may not lead to a usable test without much larger validation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Joseph's Health Centre (Unity Health Toronto)
Toronto, Ontario, Canada
-
Toronto General Hospital (University Health Network)
Toronto, Ontario, Canada